Microbicides
Rectal microbicides: investments and advocacy
Homophobia and stigma preventing the development of rectal microbicides
Authors:
C. Feuer
Publisher:
International Rectal Microbicide Working Group , 2006
This report from the International Rectal Microbicide Working Group shows that the development of rectal microbicide remains seriously under funded by both the public and private sector. The report tracks the current funding levels for research into rectal microbicides and compares this with the estimated amount that would be required to bring these microbicides up to the point of being licensed and available for use. It also provides advocates with recommendations and resources to use in pressing for change on this issue.
The development of rectal microbicides is urgent in the context of rising rates of HIV infection, and other sexually transmitted infections (STI) among many communities of men who have sex with men (MSM). But the level of unprotected anal intercourse (AI) between heterosexuals is almost five times more than between MSM. The development of these microbicides, in conjunction with vaginal microbicides, would also benefit women, and in particular women who are currently disempowered and unable to negotiate condom use with their male partners. However, the authors argue that homophobia has slowed down the progress of research into the prevention of rectally acquired infections. The report recommends that donors spend a minimum of 350 million US dollars on targeted rectal microbicide research over the next 10 to 15 years and that such research be promoted among scientists. It also recommends that non-governmental organisations (NGOs) form an international body to co-ordinate research and that advocacy groups work with the affected communities to raise awareness in preparation for clinical trials.
